Cargando…

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study

BACKGROUND: Common genetic variance in apolipoprotein E (APOE), β-glucocerebrosidase (GBA), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) has been linked to cognitive decline in Parkinson’s disease (PD), although studies have yielded mixed esults. OBJECTIVES: To evaluate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szwedo, Aleksandra A., Dalen, Ingvild, Pedersen, Kenn Freddy, Camacho, Marta, Bäckström, David, Forsgren, Lars, Tzoulis, Charalampos, Winder-Rhodes, Sophie, Hudson, Gavin, Liu, Ganqiang, Scherzer, Clemens R., Lawson, Rachael A., Yarnall, Alison J., Williams-Gray, Caroline H., Macleod, Angus D., Counsell, Carl E., Tysnes, Ole-Bjørn, Alves, Guido, Maple-Grødem, Jodi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362732/ https://www.ncbi.nlm.nih.gov/pubmed/35106798 http://dx.doi.org/10.1002/mds.28932

Ejemplares similares

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Parkinson’s disease clinical milestones and mortality
por: Gonzalez, Maria Camila, et al.
Publicado: (2022)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
por: Counsell, Carl, et al.
Publicado: (2022)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2017)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
por: Green, Samantha, et al.
Publicado: (2021)

Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease
por: Gaare, Johannes J., et al.
Publicado: (2018)

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Pedersen, Camilla Christina, et al.
Publicado: (2021)

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)

Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders
por: Pedersen, Camilla Christina, et al.
Publicado: (2023)

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)

Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population
por: Lange, Johannes, et al.
Publicado: (2015)

NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study
por: Brakedal, Brage, et al.
Publicado: (2021)

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection
por: Gjerstad, Michaela D., et al.
Publicado: (2018)

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
por: Rongve, Arvid, et al.
Publicado: (2019)

Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
por: Dick, Fiona, et al.
Publicado: (2023)

Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
por: Rongve, Arvid, et al.
Publicado: (2019)

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
por: Huh, Young Eun, et al.
Publicado: (2023)

Development of a constitutive and an auto-inducible high-yield expression system for recombinant protein production in the microalga Nannochloropsis oceanica
por: de Grahl, Imke, et al.
Publicado: (2020)

Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA
por: Guitton, Romain, et al.
Publicado: (2022)

Evolution of impulsive–compulsive behaviors and cognition in Parkinson’s disease
por: Erga, Aleksander H., et al.
Publicado: (2019)

The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD
por: Straniero, Letizia, et al.
Publicado: (2020)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition
por: Connolly, Kyle J., et al.
Publicado: (2023)

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid
por: Oftedal, Linn, et al.
Publicado: (2020)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
por: Tufekcioglu, Zeynep, et al.
Publicado: (2023)

Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood-brain barrier
por: Jakubec, Martin, et al.
Publicado: (2020)

Differential transcript usage in the Parkinson’s disease brain
por: Dick, Fiona, et al.
Publicado: (2020)

Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study
por: Erga, Aleksander H., et al.
Publicado: (2017)

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
por: Franco, Rafael, et al.
Publicado: (2018)

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci
por: Gaare, Johannes Jernqvist, et al.
Publicado: (2020)

Predictors of functional dependency in Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_874el71uecl48b5gpo183c1jld